President and CEO of bluebird bio, Inc. (U.S.: Nasdaq:BLUE), Obenshain Andrew, sells 3,042 shares worth $28,467
According to bluebird bio, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Jan 12 09:15 PM, company President and CEO, Obenshain Andrew disclosed selling 3,042 shares at a cost of $9.36. At the time of this transaction (Jan 10), this trade was worth $28,467 in total. As of Jan 10, Obenshain Andrew now owns 251,379 shares in total worth about $2,164,373.19.
For the last few recent trades made by bluebird bio, Inc. (U.S.: Nasdaq:BLUE) President and CEO, Obenshain Andrew, we have the following information:
- SEC Form 4 filing: Jan 11: Sold 4,683 shares at the rate of $9.64 per share. Total worth of this trade was $45,156. Total number of shares owned as of Jan 11 were 246,696
- SEC Form 4 filing: Dec 07: Sold 832 shares at the rate of $10.18 per share. Total worth of this trade was $8,469. Total number of shares owned as of Dec 07 were 254,421
- SEC Form 4 filing: Jun 04: Sold 511 shares at the rate of $30.75 per share. Total worth of this trade was $15,715. Total number of shares owned as of Jun 04 were 39,597
Posted by
George Daniels
on Thursday January 13 2022, 3:03 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
